Disclaimer


This is my unsolicited Point of View and is _not_ a recommendation to buy/sell the security.

*** DO NOT *** attempt to trade unless you FULLY understand the associated (financial/emotional) risks and you FULLY accept responsibility of the results of your actions.

Mind the levels. Manage the risks. Protect your capital. Protect your gains.

Keywords

StudyList (20) $PXP (12) BULLishStocks (10) $BRN (8) $TEL (8) $X (8) $BLOOM (7) $CHP (7) $CPG (7) $MRC (7) $URC (7) $APX (6) $CEI (6) $FLI (6) $JFC (5) $SGI (5) $WPI (5) $BHI (4) $CLC (4) $GERI (4) $MPI (4) $RLC (4) BobbyAxelRod (4) $ACR (3) $AGI (3) $BEL (3) $CROWN (3) $CYBR (3) $DD (3) $DNL (3) $FGEN (3) $MAXS (3) $MBT (3) $MEG (3) $MWC (3) $NOW (3) $PCOR (3) $PGOLD (3) $PLC (3) $RFM (3) $SCC (3) $SMPH (3) $TUGS (3) $VITA (3) PSEIndex (3) TopWeeklyGainersLosers (3) $ATN (2) $BDO (2) $BPI (2) $COSCO (2) $DMC (2) $EEI (2) $EMP (2) $IMI (2) $ION (2) $JGS (2) $LR (2) $LRW (2) $MED (2) $MRP (2) $MWIDE (2) $PHEN (2) $PIP (2) $ROCK (2) $RRHI (2) $SHLPH (2) $SSI (2) $STI (2) $T (2) $WEB (2) $WLCON (2) Above200dayMA (2) TopMonthlyGainersLosers (2) $2GO (1) $ABS (1) $AEV (1) $ALI (1) $ANI (1) $AT (1) $BSC (1) $CNPF (1) $COAL (1) $EW (1) $FNI (1) $FOOD (1) $FPH (1) $GSMI (1) $GTCAP (1) $HOUSE (1) $IDC (1) $LMG (1) $LTG (1) $MER (1) $MRSGI (1) $NIKL (1) $ORE (1) $PHES (1) $PIZZA (1) $POPI (1) $PPC (1) $PX (1) $ROX (1) $RWM (1) $SMC (1) $SSP (1) $VUL (1) NetForeign (1) TechnicalAnalysis (1) Volx5DAvg (1)

Tuesday, November 21, 2017

$CLC Study 20171121

$CLC Hourly Chart as of November 21, 2017
$CLC Hourly Chart as of November 21, 2017



Notes:
1. With reference to Nov. 16 reading of $CLC, we are now waiting for RSI to make the expected move up.
2. 277 trades today. 799K+ shares (not even half the 20-day Volume average).
3. CCIs are rising. Must cross over zero.
4. RSI is stil below 50.
5. Waiting for Slow Stochastic to turn up and rise.
6. Best entry is at break out level. Those with appetite for high risks may enter.

Mind the levels. Manage the risks.

No comments:

Post a Comment